Analysis of the Current Situation of Drug Clinical Trial Institutions in Shaanxi Province
Download PDF


Drug clinical trial
Institution registration
Registered majors
Current situation analysis
Professional group
Shaanxi Province



Submitted : 2023-12-19
Accepted : 2024-01-03
Published : 2024-01-18


To understand the current situation of institutional registration in Shaanxi Province after the implementation ofregistration system management in drug clinical trial institutions. Relevant information was collected on the “Announcement on the Accreditation of Drug Clinical Trial Institutions” issued by the National Medical Products Administration from 2005 to August 2022, the record management information system of drug and medical device clinical trial institutions, and the drug clinical trial registration and information publicity platform. A retrospective analysis was carried out in terms of institutional development, regional distribution, registered majors, principal investigators, and the number of drug clinical trials. After the implementation of institution registration, the number of drug clinical trial institutions in Shaanxi Province increased by 47.4%, 884 principal investigators were registered, the number of registered majors expanded from 58 qualified to 117, and the professional scope increased by 50.4%. The policy of institution registration is conducive to promoting the rational use of medical resources and the development of drug clinical trial institutions and improving the healthy development of the pharmaceutical industry in Shaanxi Province.


Fan H, Hu J, Zhao T, et al., 2023, Focus Analysis of On-Site Verification of Drug Clinical Trials Based on Efficacy Index. China Pharmaceutical Affairs, 37(08): 864–869.

Xiang Y, Huang Z, Yang G, 2021, Subject-Oriented Promoting Clinical Research Platform Construction. China Health Human Resources, 2021(10): 22–25.

Xinhua News Agency, 2017, General Office of the CPC Central Committee and General Office of the State CouncilIssued the “Opinions on Deepening the Reform of Review and Approval System to Encourage Innovation of Pharmaceutical Medical Devices,” viewed November 9, 2020.

Standing Committee of the 13th National People’s Congress, 2019, Drug Administration Law of the People’s Republic of China, viewed February 2, 2020.

National Health Commission, State Drug Administration, 2019, Announcement on the Release of Administrative Regulations on Drug Clinical Trial Institutions (No. 101 of 2019), viewed January 23, 2022.

Cao L, Guo W, Xie L, et al., 2019, Practice and Thinking on Quality Control of Clinical Trial Projects in Drug Clinical Trial Institutions. China Pharmaceutical Affairs, 23(4): 713–715.

Fang H, Fan Q, Wang X, et al., 2019, Analysis of Archival Status of Drug Clinical Trial Institutions in China. Chinese Journal of Clinical Pharmacology, 37(4): 458–460, 483.

State Food and Drug Administration, Ministry of Health, 2004, Measures for Qualification Identification of Drug Clinical Trial Institutions (Trial), viewed February 18, 2021.

Ning J, Wu H, Gao R, 2021, Analysis of Filing Requirements and Common Problems in Drug Clinical Trial Institutions. Chinese Journal of Clinical Pharmacology, 37(1): 3–7.

You Y, Gao F, Xu X, et al., 2023, Analysis on the Status Quo of Drug Clinical Trial Institutions in China After Recording System. Chinese Journal of Advanced Medicine and Clinical Medicine, 42(03): 170–174.

Huo L, Shi Z, Zhou Y, et al., 2023, Analysis of the Current Situation of Newly Registered Drug Clinical Trial Institutions in China. Chinese Journal of New Drugs and Clinical Medicine, 10: 645–650.

China Clinical Research Capacity Improvement and Subject Protection Summit Forum (CCHRPP), 2022, National GCP Institutions Drug Clinical Trial Volume Ranking Grand Release, viewed January 23, 2022.

Chinese Hospital Association, 2022, Annual Report of Chinese Hospital Drug Clinical Trials (2021), viewed January 23, 2023,

Wei Y, Wang X, 2020, Thinking on the Construction of Drug Clinical Trial Information System: A Case Study of Public Hospitals. Administrative Business Assets and Finance, 2020(5): 29–30.

China Report Hall, 2022, Clinical Trial Industry Outlook: The Number of Clinical Trials Will Further Increase in 2022, viewed June 22, 2022.